文献速递复苏、休克与脓毒症心脑血管急症

心脏骤停中静脉或骨内血管通路:个体参与者数据荟萃分析

Intravenous or intraosseous vascular access in cardiac arrest: an individual participant data meta-analysis.
PubMed 文献 · Resuscitation · 2026-09-11
一句话结论在院外心脏骤停中,骨内优先与静脉优先血管通路在30天生存、持续ROSC和良好神经结局上无统计学显著差异。

该研究为两项随机试验的个体参与者数据荟萃分析,纳入7561例院外心脏骤停患者,比较骨内优先与静脉优先血管通路。30天生存OR 1.01(95%CI 0.81-1.25,中等确定性),30天或出院时良好神经结局OR 1.08(95%CI 0.83-1.41,低确定性),持续ROSC点估计偏向静脉(OR 0.90,95%CI 0.81-1.01,低确定性)但无统计学意义。贝叶斯分析显示两种策略差异很小的概率高。临床意义:院外心脏骤停中两种通路策略均可接受,无需因通路类型延误给药。

要点

  • 院外心脏骤停成人患者中,骨内优先与静脉优先血管通路30天生存无显著差异(OR 1.01,95%CI 0.81-1.25)。
  • 良好神经结局(30天或出院时)无显著差异(OR 1.08,95%CI 0.83-1.41,低确定性证据)。
  • 持续ROSC点估计偏向静脉通路(OR 0.90,95%CI 0.81-1.01),但未达统计学显著性。
  • 贝叶斯分析提示两种策略间任何差异很小的概率高,支持临床可互换使用。
  • 证据确定性为中等至低,主要终点30天生存为中等确定性。

适用人群与场景

  • 院外心脏骤停患者,来自两项个体随机临床试验的个体参与者数据,共7561例。
  • 原文未提及排除人群、年龄范围或具体纳入标准。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及具体药物剂量、给药途径细节或操作流程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:系统综述与个体参与者数据荟萃分析,纳入两项个体随机临床试验,共7561例院外心脏骤停患者。
  • 干预与对照:骨内优先血管通路 vs 静脉优先血管通路。
  • 主要终点30天生存:OR 1.01(95%CI 0.81-1.25),中等确定性证据,无显著差异。
  • 关键次要终点良好神经结局(30天或出院时):OR 1.08(95%CI 0.83-1.41),低确定性证据,无显著差异。
  • 关键次要终点持续ROSC:OR 0.90(95%CI 0.81-1.01),低确定性证据,点估计偏向静脉但无统计学显著性。
  • 贝叶斯分析:两种策略间任何差异很小的概率高。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:两项随机临床试验的个体参与者数据荟萃分析,遵循PRISMA-IPD指南,使用GRADE方法评估证据确定性。
  • 证据等级:30天生存为中等确定性;良好神经结局和持续ROSC为低确定性。
  • 局限:仅纳入两项随机试验,原文未提及其他局限(如单中心、回顾性、开放标签、样本小等)。

对床旁实践的改变

  • 院外心脏骤停中骨内优先与静脉优先血管通路在30天生存和神经结局上无显著差异,临床可根据操作便利性选择通路,无需因通路类型延误给药。
  • 持续ROSC点估计偏向静脉通路但无统计学意义,不能据此推荐静脉优先。
  • 证据确定性中等至低,决策时应结合具体临床场景。
  • 原文未提及其他具体实践改变、适用与不适用人群或常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To perform a systematic review and individual participant data meta-analysis of randomized trials comparing intraosseous-first with intravenous-first vascular access during cardiac arrest.

METHODS: The PRISMA-IPD guidelines were followed. We searched Medline, Embase, and the Cochrane Library on March 18, 2026, for individually randomized clinical trials. Pairs of investigators reviewed studies for relevance, extracted data, and assessed risk of bias. Individual participant data meta-analyses were conducted using logistic regression with adjustment for prognostic factors. Bayesian analyses were conducted using prespecified prior distributions. The certainty of evidence was evaluated using GRADE methodology.

RESULTS: Two randomized trials provided individual participant data for 7561 patients with out-of-hospital cardiac arrest. There was no difference in 30-day survival (odds ratio, 1.01; 95% confidence interval, 0.81-1.25; moderate certainty of evidence) and favorable neurological outcome at 30 days or hospital discharge (odds ratio, 1.08; 95% confidence interval, 0.83-1.41; low certainty of evidence) between patients receiving intraosseous compared with intravenous vascular access. For sustained return of spontaneous circulation, the point estimate favored intravenous access (odds ratio, 0.90; 95% confidence interval, 0.81-1.01; low certainty of evidence), although the result was not statistically significant. Bayesian analyses found a high probability that any difference between the two strategies was small.

CONCLUSIONS: In this individual participant data meta-analysis of two randomized trials, intraosseous-first compared with intravenous-first vascular access during out-of-hospital cardiac arrest did not result in a statistically significant difference in 30-day survival, sustained return of spontaneous circulation, and favorable neurological outcome.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Holmberg MJ, Couper K, Andersen LW, et al. Intravenous or intraosseous vascular access in cardiac arrest: an individual participant data meta-analysis. Resuscitation. 2026. PMID: 42727699. doi:10.1016/j.resuscitation.2026.111304

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。